20 Oct 2004

UCB confirms third quarter Zyrtec sales in the US / 6% Increase in European Allergy Franchise

Read More
18 Oct 2004

UCB appoints Chief Financial Officer

Read More
1 Oct 2004

UCB sells Surface Specialties to Cytec for € 1.5 billion

Read More
30 Sep 2004

UCB: Closing of the sale of its films business

Read More
21 Sep 2004

UCB Pharma outlines positive preliminary results from second pivotal CDP 870 Phase III trial in rheumatoid arthritis

Read More
3 Sep 2004

Georges Jacobs announces that he will resign from his executive post on January 1, 2005

Read More
2 Sep 2004

Sale of an industrial site in France

Read More
26 Aug 2004

Reorganisation of research

Read More
29 Jul 2004

Net profit increases by 34%

Read More
19 Jul 2004

UCB has signed an agreement to sell its Films business

Read More
Subscribe to